{"id":7218,"date":"2013-07-23T18:36:56","date_gmt":"2013-07-23T23:36:56","guid":{"rendered":"http:\/\/medicinainterna.com.mx\/?p=7218"},"modified":"2013-07-23T18:36:56","modified_gmt":"2013-07-23T23:36:56","slug":"evaluacion-y-criterios-del-donante-cardiaco","status":"publish","type":"post","link":"https:\/\/medicinainterna.com.mx\/?p=7218","title":{"rendered":"Evaluaci\u00f3n y criterios del donante cardiaco."},"content":{"rendered":"

<\/h3>\n\n\n\n\n
1. Edad inferior a 35 a\u00f1os en varones y a 40 a\u00f1os en mujeres*
\n2. Ausencia de cardiopat\u00eda
\n2.1.\u00a0 Ausencia de antecedentes de enfermedad cardiaca
\n2.2.\u00a0 No historia de hipertensi\u00f3n arterial conocida
\n2.3.\u00a0 Auscultaci\u00f3n cardiaca normal
\n2.4.\u00a0 Rx de t\u00f3rax normal
\n2.5.\u00a0 ECG en ritmo sinusal, normal
\n3.\u00a0 Peso +-25% del receptor
\n4.\u00a0 Estabilidad hemodin\u00e1mica: Infusi\u00f3n de dopamina <10 mcg\/Kg\/min
\n5.\u00a0 Compatibilidad ABO
\n6.\u00a0 VIH, HB, HV negativos
\n7.\u00a0 Ausencia de:
\n7.1. Neoplasia
\n7.2. Infecci\u00f3n sist\u00e9mica
\n7.3.\u00a0 Traumatismo tor\u00e1cico significativo
\n8. Ausencia de resucitaci\u00f3n cardiopulmonar*<\/td>\n<\/tr>\n
(*) Si existe un receptor en situaci\u00f3n cr\u00edtica, reconsiderar edad e incluso valorar donante con parada cardiaca y situaci\u00f3n inestable (ecocardiograma, enzimas cardiacas y posible coronariograf\u00eda)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Fuente: HO’Connell JB, Gunnar RM, Evans RW, Fricker FJ, Hunt SA, Kirklin JK.. 24th Bethesda Conference. Cardiac transplantation. JACC 1993; 22: 8-14<\/p>\n

.<\/p>\n","protected":false},"excerpt":{"rendered":"

1. Edad inferior a 35 a\u00f1os en varones y a 40 a\u00f1os en mujeres* 2. Ausencia de cardiopat\u00eda 2.1.\u00a0 Ausencia de antecedentes de enfermedad cardiaca 2.2.\u00a0 No historia de hipertensi\u00f3n arterial conocida 2.3.\u00a0 Auscultaci\u00f3n cardiaca normal 2.4.\u00a0 Rx de t\u00f3rax normal 2.5.\u00a0 ECG en ritmo sinusal, normal 3.\u00a0 Peso +-25% del receptor 4.\u00a0 Estabilidad hemodin\u00e1mica: … Continue reading “Evaluaci\u00f3n y criterios del donante cardiaco.”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-7218","post","type-post","status-publish","format-standard","hentry","category-cardiologia"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/7218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7218"}],"version-history":[{"count":0,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/7218\/revisions"}],"wp:attachment":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}